Mostrar el registro sencillo del ítem
Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature
dc.contributor.author | Torre-Alonso, Juan Carlos | |
dc.contributor.author | Queiro, Rubén | |
dc.contributor.author | Comellas, Marta | |
dc.contributor.author | Lizán, Luis | |
dc.contributor.author | Blanch, Carles | |
dc.date.accessioned | 2018-06-18T12:00:48Z | |
dc.date.available | 2018-06-18T12:00:48Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 1177-889X | |
dc.identifier.issn | 1177-889X | |
dc.identifier.uri | http://hdl.handle.net/10234/175250 | |
dc.description.abstract | Objective: This review aims to summarize the current literature on patient-reported outcomes (PROs) in spondyloarthritis (SpA). Patients and methods: We performed a systematic literature review to identify studies (original articles and narrative and systematic reviews) regarding PROs (health-related quality of life [HRQoL], satisfaction, preferences, adherence/compliance, and persistence) in SpA patients published in the European Union through December 2016. International databases (Medline/ PubMed, Cochrane Library, ISI Web of Knowledge, Scopus) were searched using keywords in English. The methodological quality of the studies was assessed using the Oxford Centre for Evidence-Based Medicine criteria. Results: A total of 26 publications met the inclusion criteria. Generally, studies indicated that SpA has a negative impact on patients’ HRQoL. In patients with ankylosing spondylitis, physical domains were more affected than emotional ones, whereas for psoriatic arthritis, both physical and psychological factors were strongly affected by the disease. Data indicated that biological agents (BAs) greatly contributed to improvement in HRQoL in both ankylosing spondylitis and psoriatic arthritis patients. Findings on compliance with BAs were heterogeneous. However, persistence rates exceeded 50% irrespective of the BA administered. Results on preferences indicated that most SpA patients prefer being involved in decisions regarding their treatment and that besides efficacy and safety, frequency and route of administration may influence patients’ preferences for BAs. Conclusion: Implementing management programs for SpA patients focuses on the physical, emotional, and social consequences of the disease, in addition to assessing and including patient preferences in the treatment decision-making process, could be crucial to improve patients’ HRQoL and ensure their satisfaction and compliance with treatment. | ca_CA |
dc.format.extent | 15 p. | ca_CA |
dc.format.mimetype | application/pdf | ca_CA |
dc.language.iso | eng | ca_CA |
dc.publisher | Dove Medical Press | ca_CA |
dc.relation.isPartOf | Patient Preference and Adherence 2018:12 | ca_CA |
dc.rights | © 2018 Torre-Alonso et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). | ca_CA |
dc.rights | Atribución-NoComercial 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.subject | spondyloarthritis | ca_CA |
dc.subject | ankylosing spondylitis | ca_CA |
dc.subject | psoriatic arthritis | ca_CA |
dc.subject | patient-reported outcomes | ca_CA |
dc.subject | European Union | ca_CA |
dc.subject | systematic review | ca_CA |
dc.title | Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature | ca_CA |
dc.type | info:eu-repo/semantics/article | ca_CA |
dc.identifier.doi | http://dx.doi.org/10.2147/PPA.S162420 | |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca_CA |
dc.relation.publisherVersion | https://www.dovepress.com/patient-reported-outcomes-in-european-spondyloarthritis-patients-a-sys-peer-reviewed-article-PPA | ca_CA |
dc.type.version | info:eu-repo/semantics/publishedVersion | ca_CA |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
MED_Articles [673]
Articles de publicacions periòdiques
Excepto si se señala otra cosa, la licencia del ítem se describe como: © 2018 Torre-Alonso et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution – Non Commercial (unported, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0/). By accessing the work you
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).